|
||||||
Executive Summary Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2015 GlobalData's clinical trial report, "Hidradenitis Suppurativa Global Clinical Trials Review, H1, 2015" provides an overview of Hidradenitis Suppurativa clinical trials scenario. This report provides top line data relating to the clinical trials on Hidradenitis Suppurativa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope The report provides a snapshot of the global clinical trials landscape Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment The Report provides enrollment trends for the past five years Report provides latest news for the past three months Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons To Buy Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Read More Contact Us:
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Hidradenitis Suppurativa 6 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Clinical Trials by G7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials 16 Clinical Trials in E7 Countries by Trial Status 17 Clinical Trials by Phase 18 In Progress Trials by Phase 19 Clinical Trials by Trial Status 20 Clinical Trials by End Point Status 21 Unaccomplished Trials of Hidradenitis Suppurativa 22 Subjects Recruited Over a Period of Time 23 Clinical Trials by Sponsor Type 24 Prominent Sponsors 25 Top Companies Participating in Hidradenitis Suppurativa Therapeutics Clinical Trials 26 Prominent Drugs 27 Clinical Trial Profiles 28 Clinical Trial Overview of Top Companies 28 AbbVie Inc. 28 Clinical Trial Overview of AbbVie Inc. 28 AstraZeneca Plc 29 Clinical Trial Overview of AstraZeneca Plc 29 Amgen Inc. 30 Clinical Trial Overview of Amgen Inc. 30 Laboratory Corporation of America Holdings 31 Clinical Trial Overview of Laboratory Corporation of America Holdings 31 Laboratoire Labcatal 32 Clinical Trial Overview of Laboratoire Labcatal 32 Janssen Global Services, LLC 33 Clinical Trial Overview of Janssen Global Services, LLC 33 ICON plc 34 Clinical Trial Overview of ICON plc 34 F. Hoffmann-La Roche Ltd. 35 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35 Bayer AG 36 Clinical Trial Overview of Bayer AG 36 Abbott Laboratories 37 Clinical Trial Overview of Abbott Laboratories 37 Clinical Trial Overview of Top Institutes / Government 38 Erasmus MC 38 Clinical Trial Overview of Erasmus MC 38 Henry Ford Health System 39 Clinical Trial Overview of Henry Ford Health System 39 ACPM Medical College 40 Clinical Trial Overview of ACPM Medical College 40 Florida Academic Dermatology Centers 41 Clinical Trial Overview of Florida Academic Dermatology Centers 41 Massachusetts General Hospital 42 Clinical Trial Overview of Massachusetts General Hospital 42 New York University School of Medicine 43 Clinical Trial Overview of New York University School of Medicine 43 The Pennsylvania State University 44 Clinical Trial Overview of The Pennsylvania State University 44 University Medical Center Groningen 45 Clinical Trial Overview of University Medical Center Groningen 45 University of Athens 46 Clinical Trial Overview of University of Athens 46 University of California, San Francisco 47 Clinical Trial Overview of University of California, San Francisco 47 Five Key Clinical Profiles 48 Appendix 97 Abbreviations 97 Definitions 97 Research Methodology 98 Secondary Research 98 About GlobalData 99 Contact Us 99 Disclaimer 99 Source 99 List of Figures Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region (%), 2015* 7 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9 Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11 Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2015* 13 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2015* 16 Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23 Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 24 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27 GlobalData Methodology 98 List of Tables Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Region, 2015* 7 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9 Hidradenitis Suppurativa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10 Hidradenitis Suppurativa Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11 Hidradenitis Suppurativa Therapeutics Clinical Trials, North America, Top Countries, 2015* 12 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, G7 Countries (%), 2015* 13 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14 Hidradenitis Suppurativa Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15 Proportion of Hidradenitis Suppurativa to Dermatology Clinical Trials, E7 Countries (%), 2015* 16 Hidradenitis Suppurativa Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 17 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Phase, 2015* 18 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19 Hidradenitis Suppurativa Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21 Hidradenitis Suppurativa Therapeutics, Global, Terminated Clinical Trials, 2015* 22 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 23 Hidradenitis Suppurativa Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 24 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 25 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 26 Hidradenitis Suppurativa Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 27 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 28 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 29 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 30 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratory Corporation of America Holdings, 2015* 31 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoire Labcatal, 2015* 32 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 33 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by ICON plc, 2015* 34 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 35 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 36 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 37 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 38 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Henry Ford Health System, 2015* 39 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by ACPM Medical College, 2015* 40 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Florida Academic Dermatology Centers, 2015* 41 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 42 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2015* 43 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by The Pennsylvania State University, 2015* 44 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 45 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Athens, 2015* 46 Hidradenitis Suppurativa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015* 47 Single User License: Site License: Corporate User License: AbbVie Inc. AstraZeneca Plc Amgen Inc. Laboratory Corporation of America Holdings Laboratoire Labcatal Janssen Global Services, LLC ICON plc F. Hoffmann-La Roche Ltd. Bayer AG Abbott Laboratories Hidradenitis Suppurativa Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Hidradenitis Suppurativa, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania. |
select a license |
||
NEWSLETTER BY CATEGORY
|
||
Testimonials
|
||
The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center" |